Programmatic Palliative Care Consultations in Pediatric Heart Transplant Evaluations

Erika J. Mejia,Rui Xiao,Jennifer K. Walter,Chris Feudtner,Kimberly Y. Lin,Aaron G. DeWitt,Meeta Prasad Kerlin
DOI: https://doi.org/10.1007/s00246-024-03422-y
2024-03-09
Pediatric Cardiology
Abstract:Guidelines advocate for integrating palliative care into the management of heart failure (HF) and of children with life-limiting disease. The potential impact of palliative care integration into pediatric HF on patient-centered outcomes is poorly understood. The present study sought to assess the association of programmatic implementation of palliative care into the heart transplant evaluation process with hospital-free days (HFD) and end of life (EOL) treatment choices. The study included patients less than 19 years of age who underwent a heart transplant evaluation between February 2012 and April 2020 at a single center. Patients evaluated in the programmatic palliative care (PPC) era (January 2016–April 2020) were compared to patients evaluated in the pre-PPC era (February 2012–December 2015). The study included 188 patients, with 91 (48%) in the PPC era and 97 (52%) in the pre-PCC era. Children < 1 year of age at the time of the evaluation represented 32% of the cohort. 52% of patients had single ventricle physiology. PPC was not significantly associated with increased HFD (IRR 0.94 [95% CI 0.79–1.2]). PPC was however associated with intensity of EOL care with decreased mechanical ventilation (OR 0.12 [95% CI 0.02–0.789], p = 0.03) and decreased use of ionotropic support (OR 0.13 [95% CI 0.02-0.85], p =0.03). PPC in pediatric heart transplant evaluations may be associated with less invasive interventions at EOL.
pediatrics,cardiac & cardiovascular systems
What problem does this paper attempt to address?